Testing effectiveness (Phase 2)Study completedNCT00301899
What this trial is testing
Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab
Who this might be right for
Breast Cancer
National Institutes of Health Clinical Center (CC) 37